AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 51 filers reported holding AEVI GENOMIC MEDICINE INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $42,000 | – | 22,575 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
22NW, LP | 155,000 | $206,000 | 0.12% |
Birchview Capital, LP | 128,000 | $170,000 | 0.09% |
CARL DOMINO INC | 43,273 | $58,000 | 0.07% |
NORTHERN CAPITAL MANAGEMENT LLC | 106,050 | $141,000 | 0.05% |
ELEMENT CAPITAL MANAGEMENT LLC | 124,423 | $165,000 | 0.03% |
Baker Brothers Advisors | 1,618,089 | $2,152,000 | 0.02% |
SIMON QUICK ADVISORS, LLC | 24,390 | $32,000 | 0.02% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 31,390 | $42,000 | 0.02% |
WHITE PINE CAPITAL LLC | 20,000 | $27,000 | 0.01% |
LMR Partners LLP | 112,265 | $149,000 | 0.01% |